Laboratorio Echevarne   Report issue

For profit Phase 4
Founded: Barcelona Spain (1958)
Status: No NME R&D (1958)

Organization Overview

First Clinical Trial
2014
NCT02148718
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Laboratorio Echevarne

Active Ingredients

Drugs in Phase 4 Trials (3)

adalimumab (humira) (1 trial)

melatonin (2 trials)

zinc (2 trials)

Drugs in Other Trials (4)

cyanocobalamin (berocca) (1 trial)

isomaltose (1 trial)

magnesium stearate (1 trial)

methylcobalamin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Crohn Disease (Phase 4)

Encephalomyelitis (Phase 4)

Fatigue (Phase 4)

Fatigue Syndrome, Chronic (Phase 4)

Myalgia (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7